CRISPR technology was vital to defense against COVID-19
Yelena Biberman Dr. Biberman is an associate professor of political science at Skidmore College, a fellow at West Point’s Modern War Institute, and a nonresident senior fellow at the Atlantic Council’s South Asia Center The Technologies and International Politics of Genetic Warfare STRATEGIC STUDIES QUARTERLY FALL 2021 https://www.airuniversity.af.edu/Portals/10/SSQ/documents/Volume-15_Issue-3/Biberman.pdf
In 2020, the United States turned to CRISPR to battle the SARSCoV-2 coronavirus causing the COVID-19 disease. The Food and Drug Administration granted its first “emergency-use” approval for a coronavirus test involving CRISPR, selected for its ability to detect (and signal with fluorescent glow) SARS-CoV-2 genetic material from a nose, mouth, or throat swab in about an hour.40